Suppr超能文献

与急性肾衰竭和慢性肾病相关的蛋白质生物标志物。

Protein biomarkers associated with acute renal failure and chronic kidney disease.

作者信息

Perco P, Pleban C, Kainz A, Lukas A, Mayer G, Mayer B, Oberbauer R

机构信息

Krankenhaus der Elisabethinen, Linz, Austria.

出版信息

Eur J Clin Invest. 2006 Nov;36(11):753-63. doi: 10.1111/j.1365-2362.2006.01729.x.

Abstract

Acute renal failure (ARF) as well as chronic kidney disease (CKD) are currently categorized according to serum creatinine concentrations. Serum creatinine, however, has shortcomings because of its low predictive values. The need for novel markers for the early diagnosis and prognosis of renal diseases is imminent, particularly for markers reflecting intrinsic organ injury in stages when glomerular filtration is not impaired. This review summarizes protein markers discussed in the context of ARF as well as CKD, and provides an overview on currently available discovery results following 'omics' techniques. The identified set of candidate marker proteins is discussed in their cellular and functional context. The systematic review of proteomics and genomics studies revealed 56 genes to be associated with acute or chronic kidney disease. Context analysis, i.e. correlation of biological processes and molecular functions of reported kidney markers, revealed that 15 genes on the candidate list were assigned to the most significant ontology groups: immunity and defence. Other significantly enriched groups were cell communication (14 genes), signal transduction (22 genes) and apoptosis (seven genes). Among 24 candidate protein markers, nine proteins were also identified by gene expression studies. Next generation candidate marker proteins with improved diagnostic and prognostic values for kidney diseases will be derived from whole genome scans and protemics approaches. Prospective validation still remains elusive for all proposed candidates.

摘要

急性肾衰竭(ARF)以及慢性肾脏病(CKD)目前是根据血清肌酐浓度进行分类的。然而,血清肌酐存在缺点,因为其预测价值较低。对于肾脏疾病的早期诊断和预后而言,迫切需要新的标志物,尤其是在肾小球滤过未受损阶段反映内在器官损伤的标志物。本综述总结了在急性肾衰竭以及慢性肾脏病背景下讨论的蛋白质标志物,并概述了“组学”技术目前可得的发现结果。已鉴定出的一组候选标志物蛋白在其细胞和功能背景下进行了讨论。蛋白质组学和基因组学研究的系统综述显示,有56个基因与急性或慢性肾脏病相关。背景分析,即已报道的肾脏标志物的生物学过程和分子功能的相关性分析,显示候选列表上的15个基因被归入最显著的本体论组:免疫和防御。其他显著富集的组包括细胞通讯(14个基因)、信号转导(22个基因)和细胞凋亡(7个基因)。在24个候选蛋白质标志物中,有9种蛋白质也通过基因表达研究得到了鉴定。具有更高肾脏疾病诊断和预后价值的新一代候选标志物蛋白将来自全基因组扫描和蛋白质组学方法。对于所有提出的候选标志物而言,前瞻性验证仍然难以实现。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验